Cardinal Health has reduced its Scope 1 and Scope 2 greenhouse gas emissions by 13%, making progress toward its fiscal 2030 50% reduction goal. Cardinal Health’s fourth quarter revenue increased ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Construction has begun for a new 350,000 sq.-ft. logistics center in Columbus, Ohio, that will serve as Cardinal Health's centralized replenishment center for the distribution of over-the-counter ...

, opens new tab raised its annual profit forecast on Thursday, betting on strength in its pharmaceutical unit selling costly specialty drugs used to treat complex conditions such as cancer.

Cardinal Health Inc.’s shares CAH ... projecting adjusted earnings per share of at least $7.50. Fiscal third-quarter sales in the company’s pharmaceutical and specialty-solutions segment ...

Despite the nonrenewal of the OptumRx contracts, Cardinal Health reiterated its Pharmaceutical and Specialty Solutions long-term segment profit CAGR target of 4%-6% and its consolidated non-GAAP ...

(Reuters) - Cardinal Health said on Monday its contracts with ... loss of Optum contracts to impact Cardinal's 2025 profit by 45-50 cents. Cardinal has, however, not yet provided guidance for ...

Cardinal Health (NYSE:CAH) shares fell 5% on Monday after the company said its pharmaceutical distribution contracts with UnitedHealth Group’s (NYSE:UNH) OptumRx unit will not be renewed ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery ...

No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...